Detalles de la búsqueda
1.
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study.
Hepatology
; 2024 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38466796
2.
Urinary microbiome-based metagenomic signature for the noninvasive diagnosis of hepatocellular carcinoma.
Br J Cancer
; 130(6): 970-975, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38278977
3.
Extrahepatic malignancies in metabolic dysfunction-associated fatty liver disease: A nationwide cohort study.
Liver Int
; 44(3): 799-810, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38230848
4.
Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort study.
Hepatol Res
; 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38300711
5.
A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma.
Mol Cancer
; 22(1): 164, 2023 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37803338
6.
The association between alcohol consumption and the risk of hepatocellular carcinoma according to glycemic status in Korea: A nationwide population-based study.
PLoS Med
; 20(6): e1004244, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37307271
7.
Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score.
Radiology
; 307(5): e222106, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37249427
8.
Lean or diabetic subtypes predict increased all-cause and disease-specific mortality in metabolic-associated fatty liver disease.
BMC Med
; 21(1): 4, 2023 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36600263
9.
Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis.
Hepatology
; 76(2): 492-501, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35100447
10.
Fusion imaging-guided radiofrequency ablation with artificial ascites or pleural effusion in patients with hepatocellular carcinomas: the feasibility rate and mid-term outcome.
Int J Hyperthermia
; 40(1): 2213424, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37253458
11.
Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study.
J Korean Med Sci
; 38(28): e216, 2023 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37463687
12.
Evaluation of Low-Molecular-Weight Heparin for Treatment of Portal Vein Thrombosis in Liver Cirrhosis Patients.
Medicina (Kaunas)
; 59(2)2023 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36837493
13.
Comparable Efficacy Between Ongoing Versus Initiation of Antiviral Therapy at Treatment for HBV-related Hepatocellular Carcinoma.
Clin Gastroenterol Hepatol
; 20(8): 1877-1880.e3, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35181566
14.
Steatohepatitis Impairs T-cell-Directed Immunotherapies Against Liver Tumors in Mice.
Gastroenterology
; 160(1): 331-345.e6, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33010248
15.
Caspase-10 affects the pathogenesis of primary biliary cholangitis by regulating inflammatory cell death.
J Autoimmun
; 133: 102940, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36323068
16.
Association of Metabolic Risk Factors With Risks of Cancer and All-Cause Mortality in Patients With Chronic Hepatitis B.
Hepatology
; 73(6): 2266-2277, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33140415
17.
The association of fatty liver index and BARD score with all-cause and cause-specific mortality in patients with type 2 diabetes mellitus: a nationwide population-based study.
Cardiovasc Diabetol
; 21(1): 273, 2022 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36474232
18.
Comparison of biochemical response during antiviral treatment in patients with chronic hepatitis B infection.
Liver Int
; 42(2): 320-329, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34679254
19.
Young adults with nonalcoholic fatty liver disease, defined using the fatty liver index, can be at increased risk of myocardial infarction or stroke.
Diabetes Obes Metab
; 24(3): 465-472, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34726318
20.
Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis.
BMC Gastroenterol
; 22(1): 135, 2022 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35337274